Compare

HealthRX and Pallas Health

What each charges for compounded tirzepatide. Each program below shows its own form, terms and source date. The recorded price bases differ or an initial payment is unverified; no like-for-like initial-cost difference is calculated. Payment terms, forms and doses differ, so read the full records before treating the figures as equivalent.

Side by side

HealthRX

$209

Published figure · initial payment not verified

Injection, vial

◯ $209 advertised · 3-month plan

Membership	None. “There are no separate visit fees or membership fees.”
Consultation fee	None. “There are no separate visit fees or membership fees.”
Pharmacy	Not yet checked
Terms published	2 (payment not verified)

“Compounded Tirzepatide Once-weekly injection · Dual-incretin Dual-incretin therapy. Average 21% body-weight loss at 72 weeks in pivotal phase-3 trial. Compounded at a licensed 503A pharmacy. FROM $209 /mo (3-month plan) · as low as $179/mo on 12-month”

Read on healthrx.com, September 2026 · Full record TR-0377

Enroll with HealthRX

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

Pallas Health

$179

Per month · introductory offer · advertised medication price

Form not recorded

◯ $179 advertised · First month

Membership	Not disclosed
Consultation fee	$0
Pharmacy	Not disclosed
Terms published	2 (1 month, 12 weeks)

“Compounded Tirzepatide $179 first month · then $299/mo avg”

Read on pallashealth.co, September 2026 · Full record TR-0118

Visit Pallas Health

We earn nothing from this link. It opens Pallas Health's website without a paid referral.

Notes

Neither company is recommended here. This page records published program prices with the dates they were read, and adds the charges each company states are required. What suits you depends on dose, terms, and clinical fit, none of which a price comparison can settle. See what this record is and is not.

Other comparisons